Release date: 2024-08-13 10:43:47 Article From: Lucius Laos Recommended: 187
Pemigatinib is an innovative targeted therapy that provides a new treatment option for patients with FGFR2 fusion or rearranged cholangiocarcinoma.
Pemigatinib is a small molecule kinase inhibitor targeting the fibroblast growth factor receptor (FGFR), primarily for the treatment of advanced or metastatic cholangiocarcinoma caused by FGFR2 fusion or rearrangement. The fusion or rearrangement of the FGFR2 gene is an important genetic variant in the development of cholangiocarcinoma, and Pemigatinib can effectively inhibit the growth and spread of the tumor by inhibiting the activity of FGFR2.
Pemigatinib is mainly used to treat patients with cholangiocarcinoma who have tried other treatments but have not responded well, or who have a severe condition that cannot be surgically removed.
Dietary precautions and adjustments for cholangiocarcinoma patients are as follows:
Patients with cholangiocarcinoma should follow the principle of a low-fat and low-cholesterol diet, and avoid high-fat, high-salt, high-calorie foods such as fried, barbecued, and pickled, so as not to stimulate the gallbladder to secrete bile and aggravate the condition.
The diet should be dominated by light, easily digestible foods rich in protein, vitamins, and fiber. Patients need to replenish the nutrients needed by the body in time but pay attention to eating small and frequent meals to avoid overeating.
Patients should avoid alcohol, coffee, and other stimulating drinks as much as possible in daily life to reduce irritation to the body.
Patients with cholangiocarcinoma should pay attention to their daily habits in daily life to avoid aggravating the condition.
Proper exercise can promote the body's metabolism and immunity, help reduce fatigue, and improve cardiopulmonary function, and digestion and absorption. However, exercise should be carried out in moderation according to your own situation to avoid overwork.
Get enough sleep and avoid staying up late and overexerting. A good routine helps to strengthen the body's resistance.
Patients with cholangiocarcinoma should keep their skin clean and intact and not scratch the skin to avoid skin lesions and infection. Wash your skin daily with warm water to keep it clean.
【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: